Acta Scientific Microbiology (ISSN: 2581-3226)

Research Article Volume 4 Issue 7

Antimicrobial Resistance, Virulence Factors, Diversity, and Genetic Clonality of Enterococcus Species from Clinical Samples

Arezoo Asadi*

Department of Microbiology, Tehran University, Iran

*Corresponding Author: Arezoo Asadi, Department of Microbiology, Tehran University, Iran.

Received: February 12, 2021 ; Published: June 24, 2021

Abstract

Over the past decade, the emergence of antibiotic-resistant enterococci has posed critical challenges to the treatment of nosocomial infections around the world, and VRE infections have been associated with mortality and morbidity worldwide, especially in immunocompromised individuals. A total of 285 Enterococcus isolates were collected from patients referring to three major hospitals in Tehran from July to December 2012, and species were identified using biochemical tests and PCR. PCR assay and antibiotic susceptibility testing were performed to detect Enterococcus species, virulence factors, and resistance genes as well as to evaluate drug resistant isolates, respectively. The clonality of the isolates was also determined by PFGE. The isolates were found to consist of E. faecalis (65%) and E. faecium (31%) species. According to the results, 39 and 53% of E. faecalis and E. faecium isolates were resistant to the most commonly used antimicrobial agents, respectively. Also, acm (23, 64%) and hyl (6, 86%) were the most prevalent genes in E. faecalis isolates, while the most prevalent virulence genes in E. faecium isolates were cyt (7, 100%), gel (30, 97%), and asa (29, 97%). PFGE revealed a high heterogeneity among 50 VRE isolates. The emergence of multidrug-resistant and heterogeneous populations of enterococci is considered as a serious threat of global concern.

Keywords: Enterococcus; Resistance; Antimicrobials; PFGE

References

  1. Kumpu Minna., et al. "Effect of live and inactivated Lactobacillus rhamnosus GG on experimentally induced rhinovirus colds: randomised, double blind, placebo-controlled pilot trial”. Beneficial Microbes5 (2015): 631-639.
  2. Mascini EM and M J M Bonten. "Vancomycin‐resistant enterococci: consequences for therapy and infection control”.Clinical Microbiology and Infection 11 (2005): 43-56.
  3. Schouten M A., et al. "Prevalence of vancomycin-resistant enterococci in Europe”. European Journal of Clinical Microbiology and Infectious Diseases11 (2000): 816-822.
  4. Biedenbach Douglas J., et al. "Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)”. Diagnostic Microbiology and Infectious Disease1 (2004): 59-69.
  5. Nelson R R S., et al. "Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period”. Journal of Clinical Microbiology6 (2000): 2112-2116.
  6. Feizabadi Mohammad Mehdi., et al. "Drug resistant patterns of enterococci recovered from patients in Tehran during 2000-2003”. International Journal of Antimicrobial Agents5 (2004): 521-522.
  7. Christidou A., et al. "Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation”. Clinical Microbiology and Infection11 (2004): 999-1005.
  8. Chavers L S., et al. "Vancomycin-resistant enterococci: 15 years and counting”. Journal of Hospital Infection3 (2003): 159-171.
  9. Klare I., et al. "Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals”. European Journal of Clinical Microbiology and Infectious Diseases12 (2005): 815-825.
  10. Fridkin Scott K., et al. "The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 US adult intensive care units”. Annals of internal medicine3 (2001): 175-183.
  11. Talebi Malihe., et al. "Enterococcus faecium from meat, chicken and cheese”. Jundishapur Journal of Microbiology4 (2015).
  12. Humphries Romney M., et al. "CLSI methods development and standardization working group best practices for evaluation of antimicrobial susceptibility tests”. Journal of Clinical Microbiology4 (2018).
  13. Diekema Daniel J., et al. "Antimicrobial resistance trends and outbreak frequency in United States hospitals”. Clinical Infectious Diseases1 (2004): 78-85.
  14. Honarm Hamidreza., et al. "Evaluation of a PCR assay to detect enterococcus faecalis in blood and determine glycopeptides resistance genes: van A and van B”. Iranian Journal of Medical Sciences3 (2012): 194.
  15. Shahbazi Shahla., et al. "Distribution of extended-spectrum β-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran”. Journal of Global Antimicrobial Resistance14 (2018): 118-125.
  16. Noohi Nasrin and Malihe Talebi. "Diversity and Genetic Clonality of Vancomycin and Gentamicin Resistant Enterococci Isolated from Healthy Humans in Iran”. Journal of Medical Bacteriology1-2 (2019): 27-36.
  17. Abat Cédric., et al. "Low level of resistance in enterococci isolated in four hospitals, Marseille, France”. Microbial Drug Resistance3 (2016): 218-222.
  18. Suppli Morten., et al. "Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy”. Clinical Microbiology and Infection7 (2011): 1078-1083.
  19. Seyfi Mahnaz., et al. "Anti-microbial resistance of enterococci isolated from urinary tract infections in Iran”. (2008): 185-190.
  20. , et al. “Isolation, Identi Cation and Speciation of Enterococci by Conventional Method and Their Antibiogram”. National Journal of Laboratory Medicine 4.2 (2015): 1-6.
  21. Mutnick Alan H., et al. "Geographic variations and trends in antimicrobial resistance among Enterococcus faecalis and Enterococcus faecium in the SENTRY Antimicrobial Surveillance Program (1997–2000)”. Diagnostic Microbiology and Infectious Disease1 (2003): 63-68.
  22. Duez Colette., et al. "The penicillin resistance of Enterococcus faecalis JH2-2r results from an overproduction of the low-affinity penicillin-binding protein PBP4 and does not involve a psr-like geneThe GenBank accession numbers for the sequences reported in this paper are Y17797 for the 8· 4 kb segment of pDML521; AJ290435 for pbp4 of E. faecalis JH2-2; AJ276231 and AJ276232 for the psr-like gene of E. faecalis JH2-2 or JH2-2r, respectively”. Microbiology9 (2001): 2561-2569.
  23. Jadhav R K., et al. "Bacterial urinary tract infections in canines and their management”. North-East Veterinarian2 (2011): 29-16.
  24. Maschieto Andresa., et al. "Antimicrobial resistance of Enterococcus sp. isolated from the intestinal tract of patients from a university hospital in Brazil”. Memórias do Instituto Oswaldo Cruz7 (2004): 763-767.
  25. Kaçmaz Birgül and Altan Aksoy. "Antimicrobial resistance of enterococci in Turkey”. International journal of Antimicrobial Agents6 (2005): 535-538.
  26. Chajęcka-Wierzchowska., et al. "Virulence factors of Enterococcus spp. presented in food”. LWT75 (2017): 670-676.
  27. M’hir Sana., et al. "Technological, functional and safety aspects of enterococci in fermented vegetable products: a mini-review”. Annals of Microbiology2 (2012): 469-481.
  28. Golob Majda., et al. "Antimicrobial resistance and virulence genes in Enterococcus faecium and Enterococcus faecalis from humans and retail red meat”. BioMed research international2019 (2019).
  29. Weng Poh Leng., et al. "High genetic diversity of Enterococcus faecium and Enterococcus faecalis clinical isolates by pulsed-field gel electrophoresis and multilocus sequence typing from a hospital in Malaysia”. BioMed research international2013 (2013).

Citation

Citation: Arezoo Asadi. “Antimicrobial Resistance, Virulence Factors, Diversity, and Genetic Clonality of Enterococcus Species from Clinical Samples ”. Acta Scientific Microbiology 4.7 (2021): 90-97.

Copyright

Copyright: © 2021 Arezoo Asadi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate33%
Acceptance to publication20-30 days
Impact Factor0.810

Indexed In



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is October 20, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US